Company / Operating Cash Flow
Masimo Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$217.8M
FY2025
5-year range
$29.4M / $264.6M
FY2021-FY2025
Trend
+10.9%
vs FY2024
Sector context
#82 of 164
Health Care
What the data says
At $218M, Masimo's operating cash flow ranks #82 of 164 in the Health Care sector. Operating Cash Flow has increased for 3 consecutive years, from $29M in FY2022 to $218M in FY2025.
Based on SEC 10-K filings.
$218M in FY2025 with a 5-year CAGR of +0.6%.
Improved from $94M to $218M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +94.9%
- 5-Year CAGR
- +0.6%
- 10-Year CAGR
- -
Sector benchmark
#82 of 164 in Health CareTop 50% of 164This company $217.8M Sector average $1.0B
▼
-79.1% below sector average
Key checks
Key Insights
- Masimo's operating cash flow has grown for 3 consecutive years.
- 5-year CAGR of +0.6%, indicating consistent growth.
- In FY2025, operating cash flow increased 10.9% year-over-year.
- Ranks #82 out of 164 companies in the Health Care sector.
Company context
Key Data Points
- Negative profit margin: -14.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $217.8M | +10.9% |
| FY2024 | $196.4M | +108.7% |
| FY2023 | $94.1M | +220.1% |
| FY2022 | $29.4M | -88.9% |
| FY2021 | $264.6M | +25.3% |
| FY2020 | $211.1M | +276.5% |
| FY2019 | $56.1M | -86.6% |
| FY2018 | $419.1M | +647.6% |
| FY2017 | $56.1M | -41.4% |
| FY2016 | $95.6M | +73.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026